LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 62.29 | 84.90 | 2949 | 7934 | 0.3717 | 0.7194 | MN20160318_Q02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 63.99 | 84.90 | 2800 | 8212 | 0.3410 | 0.6990 | MN20160318_Q02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 63.99 | 84.90 | 2816 | 8212 | 0.3429 | 0.7004 | MN20160318_Q02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 63.99 | 84.90 | 3417 | 8212 | 0.4161 | 0.7510 | MN20160318_Q02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 63.99 | 84.90 | 3436 | 8212 | 0.4184 | 0.7525 | MN20160318_Q02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 63.99 | 84.90 | 440 | 8212 | 0.0536 | 0.2833 | MN20160318_Q02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 63.99 | 84.90 | 3316 | 8212 | 0.4038 | 0.7431 | MN20160318_Q02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 65.70 | 84.90 | 2914 | 8484 | 0.3435 | 0.7028 | MN20160318_Q02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 65.70 | 84.90 | 2928 | 8484 | 0.3451 | 0.7040 | MN20160318_Q02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 65.70 | 84.90 | 3618 | 8484 | 0.4264 | 0.7592 | MN20160318_Q02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 65.70 | 84.90 | 3640 | 8484 | 0.4290 | 0.7608 | MN20160318_Q02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 65.70 | 84.90 | 497 | 8484 | 0.0586 | 0.3048 | MN20160318_Q02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 65.70 | 84.90 | 3444 | 8484 | 0.4059 | 0.7462 | MN20160318_Q02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 67.41 | 84.90 | 3029 | 8766 | 0.3455 | 0.7063 | MN20160318_Q02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 67.41 | 84.90 | 3044 | 8766 | 0.3472 | 0.7075 | MN20160318_Q02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 67.41 | 84.90 | 3797 | 8766 | 0.4331 | 0.7649 | MN20160318_Q02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 67.41 | 84.90 | 3816 | 8766 | 0.4353 | 0.7662 | MN20160318_Q02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 67.41 | 84.90 | 478 | 8766 | 0.0545 | 0.2948 | MN20160318_Q02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 67.41 | 84.90 | 3545 | 8766 | 0.4044 | 0.7469 | MN20160318_Q02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 69.11 | 84.90 | 3192 | 8988 | 0.3551 | 0.7147 | MN20160318_Q02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 69.11 | 84.90 | 3212 | 8988 | 0.3574 | 0.7163 | MN20160318_Q02 | C10 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 69.11 | 84.90 | 3984 | 8988 | 0.4433 | 0.7721 | MN20160318_Q02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 69.11 | 84.90 | 4005 | 8988 | 0.4456 | 0.7735 | MN20160318_Q02 | J05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 69.11 | 84.90 | 559 | 8988 | 0.0622 | 0.3234 | MN20160318_Q02 | N17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 69.11 | 84.90 | 3691 | 8988 | 0.4107 | 0.7521 | MN20160318_Q02 | N17 |